LAPSE:2026.0304
Published Article

LAPSE:2026.0304
Dynamic optimization of glucose feed in cell cultivationfor monoclonal antibody production process designbalancing productivity and impurity generation
June 12, 2026
Abstract
This work presents the dynamic optimization of glucose feed in cell cultivation considering the balance between productivity and impurity generation. We first developed a mechanistic model considering cell growth promotion by glucose and cell growth inhibition by osmolarity for a newly developed, high-productivity CHO-MK cell line. For model development, fed-batch cultivation experiments were conducted at a 250 mL scale under three different glucose feeding profiles. Results from a single-objective dynamic optimization, using the glucose feed profile as a design variable, were compared to those from multi-objective problem settings with varying weights assigned to productivity and final impurity concentrations. Simulation results suggested different glucose feed profiles depending on the priority given to the mAb and impurities, where the main difference was in the generated viable cell density profiles. Productivity-focused profiles employed a low-high-intermediate feeding strategy, in which the total glucose feed over the cultivation period was set to a balanced level, with an initially low rate, followed by a gradual increase, and a later decrease. Profiles focusing on impurity reduction adopted a feeding strategy that maintained a high glucose feed throughout the cultivation period. This work demonstrated the power of mechanistic-model-based process design and is expected to encourage further model-based process design in biopharmaceutical manufacturing.
This work presents the dynamic optimization of glucose feed in cell cultivation considering the balance between productivity and impurity generation. We first developed a mechanistic model considering cell growth promotion by glucose and cell growth inhibition by osmolarity for a newly developed, high-productivity CHO-MK cell line. For model development, fed-batch cultivation experiments were conducted at a 250 mL scale under three different glucose feeding profiles. Results from a single-objective dynamic optimization, using the glucose feed profile as a design variable, were compared to those from multi-objective problem settings with varying weights assigned to productivity and final impurity concentrations. Simulation results suggested different glucose feed profiles depending on the priority given to the mAb and impurities, where the main difference was in the generated viable cell density profiles. Productivity-focused profiles employed a low-high-intermediate feeding strategy, in which the total glucose feed over the cultivation period was set to a balanced level, with an initially low rate, followed by a gradual increase, and a later decrease. Profiles focusing on impurity reduction adopted a feeding strategy that maintained a high glucose feed throughout the cultivation period. This work demonstrated the power of mechanistic-model-based process design and is expected to encourage further model-based process design in biopharmaceutical manufacturing.
Record ID
Keywords
Subject
Suggested Citation
Nemoto K, Yoshiyama Y, Morisasa M, Iwabuchi J, Hayashi Y, Badr S, Sugiyama H. Dynamic optimization of glucose feed in cell cultivationfor monoclonal antibody production process designbalancing productivity and impurity generation. Systems and Control Transactions 5:816-821 (2026) https://doi.org/10.69997/sct.174347
Author Affiliations
Nemoto K: The University of Tokyo, Department of Chemical System Engineering, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan
Yoshiyama Y: The University of Tokyo, Department of Chemical System Engineering, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan
Morisasa M: Chitose Laboratory Co., Ltd., Tech & Biz Development Division, KSP R&D C432, 3-2-1, Sakado, Takatsu-ku, Kawasaki, Kanagawa, Japan
Iwabuchi J: Chitose Laboratory Co., Ltd., Tech & Biz Development Division, KSP R&D C432, 3-2-1, Sakado, Takatsu-ku, Kawasaki, Kanagawa, Japan
Hayashi Y: The University of Tokyo, Department of Chemical System Engineering, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan
Badr S: The University of Tokyo, Department of Chemical System Engineering, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan
Sugiyama H: The University of Tokyo, Department of Chemical System Engineering, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan
[Login] to see author email addresses.
Yoshiyama Y: The University of Tokyo, Department of Chemical System Engineering, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan
Morisasa M: Chitose Laboratory Co., Ltd., Tech & Biz Development Division, KSP R&D C432, 3-2-1, Sakado, Takatsu-ku, Kawasaki, Kanagawa, Japan
Iwabuchi J: Chitose Laboratory Co., Ltd., Tech & Biz Development Division, KSP R&D C432, 3-2-1, Sakado, Takatsu-ku, Kawasaki, Kanagawa, Japan
Hayashi Y: The University of Tokyo, Department of Chemical System Engineering, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan
Badr S: The University of Tokyo, Department of Chemical System Engineering, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan
Sugiyama H: The University of Tokyo, Department of Chemical System Engineering, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan
[Login] to see author email addresses.
Journal Name
Systems and Control Transactions
Volume
5
First Page
816
Last Page
821
Year
2026
Publication Date
2026-06-12
Version Comments
Original Submission
Other Meta
PII: 0816-0821-6-SCT-5-2026, Publication Type: Journal Article
Record Map
Published Article

LAPSE:2026.0304
This Record
Document

LAPSE:2026.0040
Dynamic optimization of glucose fee...
External Link

https://doi.org/10.69997/sct.174347
Publisher Version
Download
Meta
Record Statistics
Record Views
186
Version History
[v1] (Original Submission)
Jun 12, 2026
Verified by curator on
Jun 12, 2026
This Version Number
v1
Citations
Most Recent
This Version
URL Here
https://psecommunity.org/LAPSE:2026.0304
Record Owner
PSE Press
Links to Related Works
Directly Related to This Work
Supplementary Material
Publisher Version
References Cited
- Masuda K, Kubota M, Nakazawa Y, Iwama C, Watanabe K, Ishikawa N, Tanabe Y, Kono S, Tanemura H, Takahashi S, Makino T, Okumura T, Horiuchi T, Nonaka K, Murakami S, Kamihira M, Omasa T. Establishment of a novel cell line, CHO-MK, derived from chinese hamster ovary tissues for biologics manufacturing. Journal of Bioscience and Bioengineering 137:471-479 (2024) https://doi.org/10.1016/j.jbiosc.2024.02.005
- Fan Y, Jimenez Del Val I, Müller C, Lund AM, Sen JW, Rasmussen SK, Kontoravdi C, Baycin?Hizal D, Betenbaugh MJ, Weilguny D, Andersen MR. A multi?pronged investigation into the effect of glucose starvation and culture duration on fed?batch CHO cell culture. Biotech & Bioengineering 112:2172-2184 (2015) https://doi.org/10.1002/bit.25620
- Sukwattananipaat P, Kuroda H, Yamano?Adachi N, Omasa T. Metabolomic characterization of monoclonal antibody?producing chinese hamster lung (CHL)?YN cells in glucose?controlled serum?free fed?batch operation. Biotech & Bioengineering 121:2848-2867 (2024) https://doi.org/10.1002/bit.28777
- Reyes S, Pham PL, Durocher Y, Henry O. cho stable pool fed?batch process development of sars ? cov ?2 spike protein production: impact of aeration conditions and feeding strategies. Biotechnology Progress 41: (2024) https://doi.org/10.1002/btpr.3507
- Jones W, Gerogiorgis D. Dynamic optimisation of fed-batch bioreactors for mabs: sensitivity analysis of feed nutrient manipulation profiles. Processes 11:3065 (2023) https://doi.org/10.3390/pr11113065
- Jones W, Gerogiorgis DI. Dynamic simulation, optimisation and economic analysis of fed-batch vs. perfusion bioreactors for advanced mab manufacturing. Computers & Chemical Engineering 165:107855 (2022) https://doi.org/10.1016/j.compchemeng.2022.107855
- Jones W, Gerogiorgis DI. Dynamic optimization of an integrated cultivation?aggregation model for mab production. Biotech & Bioengineering 121:2716-2727 (2024) https://doi.org/10.1002/bit.28761
- Martín-Calderón JL, Bustos F, Tuesta-Reina LR, Varona JM, Caballero L, Solano F. Choice of the best equation for plasma osmolality calculation: comparison of fourteen formulae. Clinical Biochemistry 48:529-533 (2015) https://doi.org/10.1016/j.clinbiochem.2015.03.005
(0.13 seconds)
[0.13 s]

